| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.78B | 45.93B | 42.91B | 36.11B | 37.67B | 35.92B |
| Gross Profit | 15.37B | 16.94B | 14.88B | 10.61B | 12.15B | 12.67B |
| EBITDA | 10.38B | 11.57B | 10.00B | 6.29B | 8.12B | 9.29B |
| Net Income | 4.88B | 5.61B | 4.48B | 2.12B | 3.40B | 4.46B |
Balance Sheet | ||||||
| Total Assets | 65.58B | 71.82B | 66.61B | 62.51B | 61.37B | 59.13B |
| Cash, Cash Equivalents and Short-Term Investments | 6.63B | 9.54B | 8.06B | 8.26B | 8.11B | 8.33B |
| Total Debt | 359.00M | 320.00M | 561.00M | 1.55B | 1.48B | 1.55B |
| Total Liabilities | 17.88B | 20.12B | 19.14B | 18.53B | 18.44B | 18.63B |
| Stockholders Equity | 47.70B | 51.69B | 47.46B | 43.97B | 42.92B | 40.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.59B | 1.83B | 1.66B | 2.50B | 5.13B |
| Operating Cash Flow | 0.00 | 10.14B | 8.66B | 4.99B | 5.17B | 9.11B |
| Investing Cash Flow | 0.00 | -6.12B | -6.54B | -3.09B | -3.55B | -3.93B |
| Financing Cash Flow | 0.00 | -2.62B | -2.36B | -1.79B | -1.90B | -1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥174.90B | 11.62 | 10.24% | 2.43% | 7.59% | 9.69% | |
77 Outperform | ¥141.46B | 21.73 | ― | 1.79% | 7.03% | 26.11% | |
69 Neutral | ¥767.85B | 16.33 | 27.58% | 0.99% | 8.43% | 225.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥1.59T | 20.78 | 3.37% | 1.85% | 0.85% | 8.37% | |
58 Neutral | ¥12.52B | 14.23 | ― | 4.80% | 13.99% | 3.21% | |
54 Neutral | ¥108.17B | 233.67 | 2.80% | 3.38% | -4.52% | -91.68% |